Prospective Evaluation of Low-dose Irinotecan and Cyberknife Stereotactic Body Radiotherapy in the Treatment of Patients With Colorectal Cancer and Limited Liver Metastasis
Phase of Trial: Phase II
Latest Information Update: 22 Sep 2015
At a glance
- Drugs Irinotecan (Primary)
- Indications Colorectal cancer; Liver metastases
- Focus Adverse reactions
- Sponsors Advocate Health Care
- 18 Sep 2015 Protocol has been amended in treatment table in change in SBRT dose and duration.
- 18 Sep 2015 Planned End Date changed from 1 Oct 2023 to 1 Oct 2025, as reported by ClinicalTrials.gov.
- 18 Sep 2015 Planned primary completion date changed from 1 Oct 2018 to 1 Oct 2020, as reported by ClinicalTrials.gov.